av/bausch-health-companies--big.svg

NYSE:BHC

Bausch Health Companies Inc.

  • Stock

USD

Last Close

9.42

13/05 20:00

Market Cap

4.02B

Beta: 0.98

Volume Today

275.06K

Avg: 4.29M

PE Ratio

−2.93

PFCF: 2.98

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
707.11M
-
916.78M
29.65%
1.10B
20.38%
1.16B
5.00%
1.05B
9.00%
991M
6.02%
1.02B
2.98%
1.10B
7.84%
1.04B
5.18%
1.04B
0.19%
1.32B
26.45%
average payables
277.18M
-
362.49M
30.78%
415.85M
14.72%
378.85M
8.90%
344.50M
9.07%
388M
12.63%
457M
17.78%
420M
8.10%
372M
11.43%
464M
24.73%
620M
33.62%
average receivables
1.36B
-
1.95B
42.58%
2.38B
22.42%
2.60B
9.26%
2.32B
10.70%
2.00B
14.03%
1.85B
7.28%
1.71B
7.78%
1.68B
1.87%
1.78B
6.35%
1.89B
6.26%
book value per share
15.95
-
15.84
0.68%
17.02
7.46%
9.08
46.68%
16.70
84.03%
7.81
53.23%
3.02
61.35%
1.51
50.08%
-0.30
119.60%
-1.91
545.63%
-2.80
46.88%
capex per share
-0.58
-
-1.40
143.51%
-0.87
37.76%
-0.84
4.06%
-0.96
14.51%
-0.67
29.99%
-0.79
17.55%
-0.87
10.24%
-0.79
9.41%
-0.74
6.34%
-0.75
0.94%
capex to depreciation
-0.09
-
-0.27
195.18%
-0.12
57.38%
-0.10
12.04%
-0.12
15.79%
-0.08
29.09%
-0.13
60.71%
-0.17
26.38%
-0.18
7.70%
-0.19
5.43%
-0.22
11.93%
capex to operating cash flow
-0.18
-
-0.21
15.53%
-0.14
32.79%
-0.14
1.16%
-0.15
5.23%
-0.16
6.70%
-0.19
18.30%
-0.28
50.17%
-0.20
28.65%
0.37
285.50%
-0.26
171.60%
capex to revenue
-0.03
-
-0.06
77.65%
-0.03
49.27%
-0.03
4.12%
-0.04
28.04%
-0.03
27.19%
-0.03
15.26%
-0.04
19.10%
-0.03
12.83%
-0.03
1.69%
-0.03
5.84%
cash per share
1.87
-
0.96
48.57%
1.72
78.81%
1.56
9.26%
2.06
31.74%
2.06
0.23%
9.21
346.94%
1.70
81.50%
1.62
4.85%
1.55
4.16%
2.60
66.99%
days of inventory on hand
169.17
-
153.89
9.03%
173.41
12.68%
148.32
14.47%
150.13
1.22%
145.01
3.41%
171.94
18.57%
177.55
3.26%
151.40
14.73%
168.30
11.16%
220.23
30.86%
days payables outstanding
62.64
-
64.43
2.86%
59.85
7.11%
45.29
24.32%
52.29
15.44%
63.81
22.04%
78.13
22.44%
54.69
29.99%
62.05
13.46%
80.44
29.63%
102.55
27.49%
days sales outstanding
114.81
-
91.69
20.14%
93.41
1.88%
94.97
1.66%
89.12
6.16%
81.23
8.85%
78.04
3.93%
71.71
8.11%
76.82
7.12%
80.42
4.69%
83.28
3.55%
debt to assets
0.62
-
0.58
6.80%
0.64
9.69%
0.69
7.96%
0.68
1.05%
0.91
33.48%
0.76
15.57%
0.77
0.28%
0.78
1.16%
0.81
4.21%
0.82
1.25%
debt to equity
3.40
-
2.87
15.39%
5.26
83.17%
9.47
79.98%
4.35
54.07%
9.10
109.10%
24.36
167.81%
44.72
83.58%
-213.72
577.90%
-30.01
85.96%
-21.91
27.00%
dividend yield
0.23
-
0.51
-
earnings yield
-0.02
-
0.02
182.86%
-0.01
139.65%
-0.48
6,245.06%
0.32
165.69%
-0.64
303.21%
-0.17
73.59%
-0.08
55.15%
-0.09
24.29%
-0.09
1.16%
-0.20
117.03%
enterprise value
54.39B
-
62.80B
15.48%
65.68B
4.58%
34.33B
47.74%
32.35B
5.77%
30.38B
6.07%
33.18B
9.22%
30.68B
7.54%
32.00B
4.30%
22.47B
29.77%
24.37B
8.41%
enterprise value over ebitda
17.28
-
15.20
12.07%
12.92
15.00%
6.29
51.31%
9.49
50.92%
9.57
0.83%
18.19
90.06%
12.19
33.02%
12.38
1.59%
8.69
29.77%
8.43
3.00%
ev to operating cash flow
52.20
-
27.37
47.56%
29.85
9.06%
16.45
44.90%
14.12
14.13%
20.24
43.31%
22.11
9.22%
27.62
24.92%
22.44
18.74%
-30.87
237.57%
23.61
176.48%
ev to sales
9.43
-
7.60
19.37%
6.26
17.68%
3.55
43.28%
3.71
4.49%
3.63
2.21%
3.86
6.42%
3.82
0.93%
3.79
0.74%
2.77
27.09%
2.78
0.58%
free cash flow per share
2.67
-
5.44
103.71%
5.46
0.44%
5.17
5.33%
5.58
7.90%
3.62
35.15%
3.47
4.01%
2.26
34.96%
3.18
40.97%
-2.74
186.18%
2.08
175.89%
free cash flow yield
0.02
-
0.04
67.23%
0.05
41.52%
0.36
563.78%
0.26
28.38%
0.20
23.70%
0.12
40.64%
0.11
6.18%
0.12
5.68%
-0.44
480.67%
0.26
159.31%
graham net net
-63.35
-
-55.35
12.63%
-114.29
106.50%
-107.43
6.00%
-81.99
23.68%
-63.01
23.15%
-78.25
24.18%
-79.60
1.73%
-74.75
6.10%
-63.31
15.30%
-66.36
4.82%
graham number
31.11
-
31.15
0.13%
17.13
45.01%
37.64
119.67%
50.79
34.95%
45.65
10.12%
18.55
59.37%
7.31
60.60%
4.17
43.00%
5.01
20.19%
10.11
101.97%
income quality
-1.21
-
2.52
308.51%
-7.65
403.93%
-0.87
88.66%
0.95
209.91%
-0.36
138.02%
-0.84
132.42%
-1.99
136.09%
-1.52
23.43%
3.43
325.64%
-1.69
149.19%
intangibles to total assets
0.81
-
0.78
3.24%
0.85
8.77%
0.80
6.31%
0.82
3.12%
0.92
11.51%
0.69
24.80%
0.69
0.01%
0.66
3.52%
0.68
1.63%
0.64
4.50%
interest coverage
-0.49
-
2.10
533.11%
0.99
52.66%
-0.31
131.00%
0.06
117.98%
-1.41
2,652.25%
-0.05
96.80%
0.44
1,073.11%
0.85
92.55%
0.94
10.28%
0.73
22.51%
interest debt per share
56.77
-
48.40
14.76%
94.06
94.36%
91.24
3.00%
77.91
14.61%
75.87
2.62%
78.12
2.97%
71.72
8.20%
67.09
6.44%
61.26
8.70%
64.99
6.10%
inventory turnover
2.16
-
2.37
9.92%
2.10
11.25%
2.46
16.91%
2.43
1.20%
2.52
3.53%
2.12
15.66%
2.06
3.16%
2.41
17.27%
2.17
10.04%
1.66
23.58%
invested capital
3.40
-
2.87
15.39%
5.26
83.17%
9.47
79.98%
4.35
54.07%
9.10
109.10%
24.36
167.81%
44.72
83.58%
-213.72
577.90%
-30.01
85.96%
-21.91
27.00%
market cap
37.61B
-
47.87B
27.28%
35.18B
26.51%
5.02B
85.74%
7.62B
51.92%
6.47B
15.09%
10.53B
62.75%
7.36B
30.10%
9.93B
34.86%
2.27B
77.11%
2.92B
28.67%
net current asset value
-18.85B
-
-16.73B
11.28%
-37.43B
123.78%
-35.19B
5.97%
-26.81B
23.83%
-23.91B
10.81%
-25.76B
7.73%
-25.25B
1.96%
-23.63B
6.43%
-21.18B
10.37%
-21.84B
3.10%
net debt to ebitda
5.33
-
3.61
32.21%
6.00
65.99%
5.37
10.48%
7.26
35.11%
7.53
3.81%
12.42
64.85%
9.26
25.43%
8.54
7.80%
7.82
8.47%
7.42
5.03%
net income per share
-2.70
-
2.72
200.94%
-0.77
128.14%
-6.94
804.96%
6.86
198.97%
-11.86
272.71%
-5.06
57.29%
-1.57
68.90%
-2.61
65.80%
-0.58
77.62%
-1.62
177.72%
operating cash flow per share
3.25
-
6.84
110.77%
6.34
7.40%
6.01
5.15%
6.54
8.82%
4.29
34.39%
4.26
0.63%
3.13
26.59%
3.97
26.96%
-2.01
150.49%
2.83
240.98%
payables turnover
5.83
-
5.66
2.78%
6.10
7.66%
8.06
32.14%
6.98
13.37%
5.72
18.06%
4.67
18.33%
6.67
42.84%
5.88
11.86%
4.54
22.86%
3.56
21.56%
receivables turnover
3.18
-
3.98
25.21%
3.91
1.85%
3.84
1.64%
4.10
6.56%
4.49
9.71%
4.68
4.09%
5.09
8.83%
4.75
6.65%
4.54
4.48%
4.38
3.43%
research and ddevelopement to revenue
0.03
-
0.03
9.55%
0.06
86.47%
0.05
15.27%
0.04
10.80%
0.05
17.76%
0.05
10.84%
0.06
2.83%
0.06
2.09%
0.07
18.10%
0.07
5.92%
return on tangible assets
-0.16
-
0.16
198.50%
-0.04
122.87%
-0.27
649.31%
0.36
231.97%
-1.80
601.24%
-0.17
90.60%
-0.06
65.98%
-0.10
66.13%
-0.03
73.42%
-0.06
139.79%
revenue per share
17.97
-
24.64
37.07%
30.23
22.70%
27.85
7.86%
24.91
10.57%
23.95
3.85%
24.43
1.99%
22.61
7.44%
23.50
3.93%
22.39
4.74%
24.00
7.20%
roe
-0.17
-
0.17
201.63%
-0.05
126.19%
-0.76
1,597.08%
0.41
153.78%
-1.52
469.27%
-1.68
10.51%
-1.04
37.71%
8.84
946.01%
0.31
96.53%
0.58
89.08%
roic
-0.01
-
0.08
792.14%
0.09
3.89%
-0.02
119.72%
-0.00
73.46%
-0.09
1,815.01%
-0.00
96.95%
0.02
729.33%
0.05
196.87%
0.11
128.41%
0.07
37.04%
sales general and administrative to revenue
shareholders equity per share
15.95
-
15.84
0.68%
17.02
7.46%
9.08
46.68%
16.70
84.03%
7.81
53.23%
3.02
61.35%
1.51
50.08%
-0.30
119.60%
-1.91
545.63%
-2.80
46.88%
stock based compensation to revenue
0.01
-
0.01
20.06%
0.01
41.01%
0.02
27.81%
0.01
41.53%
0.01
4.11%
0.01
14.23%
0.01
10.30%
0.02
16.02%
0.02
2.19%
0.02
2.81%
tangible asset value
-17.37B
-
-15.17B
12.66%
-35.61B
134.75%
-31.42B
11.76%
-24.86B
20.88%
-22.33B
10.19%
-22.19B
0.61%
-20.88B
5.89%
-19.44B
6.92%
-17.09B
12.10%
-17.72B
3.71%
tangible book value per share
-54.10
-
-45.22
16.41%
-102.52
126.70%
-90.47
11.76%
-70.99
21.53%
-63.82
10.10%
-63.02
1.24%
-58.83
6.66%
-54.16
7.93%
-47.08
13.07%
-48.56
3.14%
working capital
1.37B
-
1.46B
6.47%
194.60M
86.69%
1.47B
654.37%
478M
67.44%
-3.11B
751.26%
721M
123.16%
429M
40.50%
409M
4.66%
306M
25.18%
1.29B
322.88%

All numbers in USD (except ratios and percentages)